Core Reminder: The newly revised Regulations focus on 4 core dimensions for foreign pharmaceutical enterprises: compliance, market access, innovation and liability, with concise and key requirement...

Policy Interpretation from the Chinese Authority

Law office's discussion on FDA's draft guidance

Practical insights on China's newly released pharmaceutical guidelines